Health
US FDA refused to approve Merck’s chronic cough drug
The US Food and Drug Administration has refused to approve Merck’s drug for the treatment of chronic cough. The health regulator concluded that the company’s
Sanofi discontinues cancer research programme to evaluate tusamitamab ravtansine
French healthcare company Sanofi on Thursday said it was ending a programme to evaluate tusamitamab ravtansine linked to the treatment of various types of lung
US FDA approves first test to detect risk of addiction to opioids
The US Food and Drug Administration said it has approved the first test to assess whether certain people are at risk of addiction to opioids.
WHO states that the JN.1 COVID strain is a “variant of interest” and poses a low risk
The World Health Organisation has classified the JN.1 coronavirus strain as a “variant of interest” and said current data show that the public health risk
US FDA approves first test to detect risk of addiction to opioids
The US Food and Drug Administration said it has approved the first test to assess whether certain people are at risk of addiction to opioids.
Doctors-in-training in England step up strikes
Doctors in training in England have stepped up their industrial action, initiating the first walkout of their biggest strike to date. Hospitals warn that this
Novo owner to direct $265m Wegovy to respiratory diseases
The Novo Nordisk Foundation announced that the government will provide up to $265 million for an initiative to improve vaccines against respiratory diseases. Novo Nordisk’s
Planned Parenthood rejected a ban on abortion in Kentucky
Lawyers for Planned Parenthood and other groups said Monday they dropped a class action lawsuit challenging Kentucky’s near-total abortion ban after the named plaintiff lost
BioNTech plans to start mRNA vaccine production in Rwanda in 2025
COVID-19 vaccine maker BioNTech plans to start production of its mRNA vaccine plant in Rwanda in 2025, company officials said on Monday, the first mRNA
Novo to spend 265 million of Wegovy’s revenues on respiratory diseases
The Novo Nordisk Foundation, which controls drug maker Novo Nordisk, said Monday the government will allocate up to 1.8 billion Danish kroner ($265 million) for